Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03216980 · ClinicalTrials.gov registry record · NA
Examining the Effect of Mental Health Disorders on Vascular Function and Exercise Tolerance
A NA study of Mental Health Disorders, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT03216980: Completed NA study of Mental Health Disorders, sponsored by Virginia Commonwealth University.
NCT03216980 is a NA study of Mental Health Disorders that has completed, run by Virginia Commonwealth University. The registered enrollment target is 40 participants, below the 1,411-participant average among 6 other Mental Health Disorders trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03216980, a NA study of Mental Health Disorders, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Specific Aim #1: Examining the impact of mental health disorders (PTSD and GAD) on peripheral vascular function and sympathetic nervous system activity in young individuals. Specific Aim #2: Examining the impact of mental health disorders (PTSD and GAD) on peripheral hemodynamics and metabolic byproducts during small muscle mass exercise in young individuals. Specific Aim #3: Examining the impact of mental health disorders (PTSD and GAD) on exercise tolerance, peripheral hemodynamics and metabolic byproducts during large muscle mass exercise in young individuals.
Primary Outcome
Change in Brachial Artery Dilation from Baseline Values
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT PTSD/GAD Antioxidant
- DIETARY_SUPPLEMENT PTSD/GAD Placebo
- DIETARY_SUPPLEMENT Healthy Control Antioxidant
- DIETARY_SUPPLEMENT Healthy Control Placebo
Study Locations (1)
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2017-05-15 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
What the finished NCT03216980 record still lists
NCT03216980 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,411-participant average among 6 other Mental Health Disorders trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Mental Health Disorders appearing as the primary indexed condition, and to 4 interventions - of which PTSD/GAD Antioxidant is the first listed.
NCT03216980 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT03216980 about?
NCT03216980 is a clinical study titled "Examining the Effect of Mental Health Disorders on Vascular Function and Exercise Tolerance". Specific Aim #1: Examining the impact of mental health disorders (PTSD and GAD) on peripheral vascular function and sympathetic nervous system activity in young individuals. Specific Aim #2: Examining the impact of mental health disorders (PTSD and GAD) on peripheral hemodynamics and metabolic bypr...
What is the current status of trial NCT03216980?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2017-05-15. Estimated completion is 2021-03-31.
What conditions does trial NCT03216980 study?
This clinical trial studies the following conditions: Mental Health Disorders.
What interventions are being tested in trial NCT03216980?
The interventions under investigation include: PTSD/GAD Antioxidant (DIETARY_SUPPLEMENT), PTSD/GAD Placebo (DIETARY_SUPPLEMENT), Healthy Control Antioxidant (DIETARY_SUPPLEMENT), Healthy Control Placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03216980?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03216980 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mental Health Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Supporting Treatment Access and Recovery Through Linkage and Support
RECRUITING · NA
-
DECIDE to Improve Maternal Mental Health Care Delivery
RECRUITING · NA
-
Effectiveness of the SoundHeal Multi-Sensory Integrative Therapy Among Justice-Involved Youth
RECRUITING · NA
-
Hybrid Collaborative Care Randomized Program Evaluation
COMPLETED · NA
-
Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI